Raul J Andrade
Overview
Explore the profile of Raul J Andrade including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
233
Citations
4910
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao T, Xia M, Hayashi P, Pan B, Aithal G, Lucena M, et al.
Liver Int
. 2025 Jan;
45(2):e70011.
PMID: 39868816
Background And Aims: Acute liver failure (ALF) is a serious condition, typically in individuals without prior liver disease. Drug-induced ALF (DIALF) constitutes a major portion of ALF cases. Our research...
2.
3.
Gillessen A, Angelico F, Chen J, Lu L, Lucena M, Fu Q, et al.
Gastro Hep Adv
. 2024 Aug;
1(5):882-893.
PMID: 39131840
Chronic liver disease (CLD) is a leading health problem impacting the quality of life globally. China shares a major global burden of CLD-including alcoholic liver disease, nonalcoholic fatty liver disease/metabolic...
4.
Gil-Pitarch C, Serrano-Macia M, Simon J, Mosca L, Conter C, Rejano-Gordillo C, et al.
Cell Rep Med
. 2024 Jul;
5(7):101653.
PMID: 39019009
Drug-induced liver injury (DILI) is a significant cause of acute liver failure (ALF) and liver transplantation in the Western world. Acetaminophen (APAP) overdose is a main contributor of DILI, leading...
5.
Bessone F, Hernandez N, Medina-Caliz I, Garcia-Cortes M, Schinoni M, Mendizabal M, et al.
Clin Gastroenterol Hepatol
. 2024 Jul;
23(1):89-102.
PMID: 38992407
Background & Aims: Latin America is a region of great interest for studying the clinical presentation of idiosyncratic drug-induced liver injury (DILI). A comprehensive analysis of patients enrolled into the...
6.
Gallego-Duran R, Ampuero J, Maya-Miles D, Pastor-Ramirez H, Montero-Vallejo R, Rivera-Esteban J, et al.
United European Gastroenterol J
. 2024 Jun;
12(8):1056-1068.
PMID: 38894596
Aim: We aimed to assess the role of FGF21 in metabolic dysfunction-associated steatotic liver disease (MASLD) at a multi-scale level. Methods: We used human MASLD pathology samples for FGF21 gene...
7.
Garcia-Cortes M, Pinazo-Bandera J, Lucena M, Andrade R
Clin Liver Dis (Hoboken)
. 2024 Jun;
23(1):e0172.
PMID: 38872768
No abstract available.
8.
Alvarado-Tapias E, Maya-Miles D, Albillos A, Aller R, Ampuero J, Andrade R, et al.
Gastroenterol Hepatol
. 2024 May;
47(10):502207.
PMID: 38723772
This is the summary report of the 5th Translational Hepatology Meeting, endorsed by the Spanish Association for the Study of the Liver (AEEH) and held in Seville, Spain, in October...
9.
Segovia-Zafra A, Villanueva-Paz M, Serras A, Matilla-Cabello G, Bodoque-Garcia A, Di Zeo-Sanchez D, et al.
J Hepatol
. 2024 May;
81(4):630-640.
PMID: 38703829
Background & Aims: Idiosyncratic drug-induced liver injury (DILI) is a complex and unpredictable event caused by drugs, and herbal or dietary supplements. Early identification of human hepatotoxicity at preclinical stages...
10.
Ruiz-Cobo J, Llaneras J, Forns X, Gallego Moya A, Conde Amiel I, Arencibia A, et al.
Aliment Pharmacol Ther
. 2024 May;
60(2):201-211.
PMID: 38695095
Background: Sofosbuvir, velpatasvir and voxilaprevir (SOF/VEL/VOX) is the recommended rescue therapy for patients with chronic hepatitis C infection who fail direct-acting antivirals (DAAs). Data are limited on the effectiveness of...